# FDA Inspection 1169672 - Vitalant - April 26, 2022

Source: https://www.keypedia.com/records/fda_inspections/vitalant/905f902a-e052-4e06-ab8c-c27b4d2e0e28
Source feed: FDA_Inspections

> FDA Inspection 1169672 for Vitalant on April 26, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169672
- Company Name: Vitalant
- Inspection Date: 2022-04-26
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1295718 - 2025-12-10](https://www.keypedia.com/records/fda_inspections/vitalant/4e853130-fd51-42f7-b06d-b6899b240d1b)
- [FDA Inspection 1295718 - 2025-12-10](https://www.keypedia.com/records/fda_inspections/vitalant/a33ad7f9-0ce8-4f33-b51b-bc0b23ca2fed)
- [FDA Inspection 1169672 - 2022-04-26](https://www.keypedia.com/records/fda_inspections/vitalant/be5d1653-2f50-4b88-96fb-10d64e15fc0d)
- [FDA Inspection 1049077 - 2018-04-03](https://www.keypedia.com/records/fda_inspections/vitalant/15cff601-a952-469a-b774-4da99ff63a61)
- [FDA Inspection 1027847 - 2017-09-28](https://www.keypedia.com/records/fda_inspections/vitalant/0a82562a-e1d3-4cf1-bba3-9a0c95dae078)

Company: https://www.keypedia.com/companies/vitalant/ebf87af6-5c34-4850-b904-61127c94a27a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d